CanPharm: Your Comprehensive Pharmaceuticals Resource - Page 3
Import Alerts: How the FDA Blocks Drugs from Non-Compliant Manufacturers
The FDA uses Import Alerts to block drugs from non-compliant manufacturers before they reach U.S. patients. Learn how the Green List system works, why shipments get detained, and what it means for global drug supply chains.
European Generic Markets: How Regulatory Approaches Across the EU Shape Drug Access and Competition
The EU's generic drug approval system is complex, with four different pathways, each affecting how quickly and where a generic reaches patients. The 2025 reforms have changed data protection, launch timelines, and supply rules-shifting how manufacturers enter the market.
-
6.03.26 -
Alistair Mukondiwa -
12
How to Communicate Past Drug Reactions Before Surgery
Knowing how to clearly communicate past drug reactions before surgery can prevent life-threatening complications. Learn what counts as a true allergy, who needs to know, and how to ensure your history is properly documented for safe anesthesia.
-
5.03.26 -
Alistair Mukondiwa -
13
Obesity as a Chronic Disease: Understanding Metabolic Health and Realistic Weight Strategies
Obesity is a chronic disease driven by biology, not choice. Learn how metabolic dysfunction, genetics, and modern treatments like GLP-1 agonists are changing how we manage weight - and why willpower alone doesn't work.
-
3.03.26 -
Alistair Mukondiwa -
0
Packaging and Labeling: How to Verify the Authenticity of Generic Medicines
Learn how to spot fake generic medicines by checking packaging, using UV lights, scanning barcodes, and recognizing subtle differences. Real-world tips from pharmacists and experts to protect your health.
-
27.02.26 -
Alistair Mukondiwa -
0
Generics vs Brand Biologics: How Much Do They Really Cost?
Biosimilars cut the cost of biologic drugs by over 50% on average, yet most patients still pay full price. Learn why the savings are real, why adoption is slow, and how you can access lower-cost alternatives.
-
26.02.26 -
Alistair Mukondiwa -
0
RSV Infections: Risks for Infants, Older Adults, and How to Prevent Them
RSV is the leading cause of hospitalization in infants and a major threat to older adults. Learn the real risks, how it spreads, and the new vaccines and preventions that are changing outcomes.
-
24.02.26 -
Alistair Mukondiwa -
15
Using Copay Cards Safely: Access Without Compromising Care
Copay cards help patients afford expensive medications-but hidden insurer policies like accumulator programs can leave you owing thousands when the card runs out. Learn how to protect your treatment and avoid dangerous financial surprises.
-
17.02.26 -
Alistair Mukondiwa -
11
How to Appeal Insurance Denials for Brand-Name Medications
Learn how to successfully appeal insurance denials for brand-name medications with step-by-step guidance, real-world examples, and key documentation tips to get your prescription covered.
-
13.02.26 -
Alistair Mukondiwa -
10
Generic Drug Quality Standards: FDA Requirements and Testing
Generic drugs must meet the same strict quality, safety, and effectiveness standards as brand-name drugs. The FDA ensures this through rigorous testing, manufacturing oversight, and bioequivalence requirements - making generics safe, reliable, and affordable.
-
10.02.26 -
Alistair Mukondiwa -
13
- Drug Information (77)
- Health and Wellness (60)
- Pharmacy Information (35)
- Medical Conditions (25)
- Supplements (5)
- Diabetes (5)
- Travel Health (3)
- Mental Health (3)
- Heart Health (2)
- Parenting (2)
-
How Antioxidants Help Manage Proctitis: Benefits, Sources, and Safe Use
5 Oct 2025 -
PDE5 Inhibitors and Nitrates: How Their Interaction Causes Dangerous Blood Pressure Drops
28 Jan 2026 -
How Dementia Affects Memory and Cognitive Function
17 Oct 2025 -
Loperamide Abuse: Risks and Warning Signs of OTC Antidiarrheal Misuse
5 Jan 2026 -
Medication Storage and Disposal: How to Safely Handle Prescriptions at Home and Beyond
8 Dec 2025
10.03.26
Alistair Mukondiwa
11